Skip to main content
. 2020 Jun 25;8:563. doi: 10.3389/fbioe.2020.00563

Figure 5.

Figure 5

Strategy of choice for the optimal carrier performances of encapsulation of EOs for biomedical application and enhanced bioavailability. (A) hydrogel bead, (B) monolayer capsule, (C) multilayer capsule, (D) composite bead, (E) liposome.